Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

NCT00321672 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
HIV Infections
Peripheral Nervous System Diseases

Interventions

DRUG: NGX-4010, 8% capsaicin patch
DRUG: 0.04% capsaicin patch
DRUG: NGX-4010, 8% capsaicin patch
DRUG: 0.04% capsaicin patch

Sponsor

NeurogesX